Beam Therapeutics Inc. (BEAM) vs Fortrea Holdings Inc. (FTRE)

A side-by-side comparison of Beam Therapeutics Inc. and Fortrea Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare
Beam Therapeutics Inc. logo
BEAM
Beam Therapeutics Inc.
$2.52B
$24.50HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Fortrea Holdings Inc. logo
FTRE
Fortrea Holdings Inc.
$1.90B
$20.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — BEAM vs FTRE

growth of $100 · dividends reinvested · last 3y
BEAM -27.3% (-10.1%/yr)FTRE -37.5% (-14.5%/yr)BEAM compounded faster over this window
50100Start $100202420252026$73$63
BEAM FTRE

BEAM vs FTRE: by the numbers

  • •BEAM is the larger company ($2.52B vs $1.90B market cap).
  • •Both run net losses; FTRE's is the smaller (-3.18% vs -54.75% net margin).
  • •BEAM grew revenue faster over the past five years (479.04% vs 1.09% CAGR).

Metrics side by side

Valuation

MetricBEAMFTRE
Forward P/EN/A23.78
P/S ratio16.150.71
P/B ratio2.363.63
EV / EBITDAN/A31.92
FCF yieldN/A7.92%

Profitability

MetricBEAMFTRE
Gross margin84.05%17.11%
Operating margin-274.57%0.41%
Net margin-54.75%-3.18%
ROE-8.00%-16.25%
ROIC-28.96%0.62%

Growth (annualized)

MetricBEAMFTRE
Revenue CAGR (5Y)479.04%1.09%
FCF CAGR (5Y)N/A-12.98%
Total return CAGR (5Y)-22.27%N/A

Frequently asked

Which has grown faster, BEAM or FTRE?
Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus FTRE at 1.09%.

Go deeper

Full BEAM analysisFull FTRE analysisInteractive comparison tool

Dig into the metrics

Beam Therapeutics ROEFortrea ROEBeam Therapeutics operating marginFortrea operating marginBeam Therapeutics revenue growthFortrea revenue growthBeam Therapeutics free cash flowFortrea free cash flow

Beam Therapeutics & Fortrea appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.